Table 1 Characteristics of control and AD subjects examined in this study
Case # | Age (y) | Gender | Diagnosis | Disease duration (y) | ApoE genotype | PMI (h) | Braak stage |
|---|---|---|---|---|---|---|---|
C1 | 76 | F | Control | NA | 3/3 | 24 | 1 |
C2 | 80 | F | Control | NA | 2/4 | 54 | 1 |
C3 | 76 | M | Control | NA | 3/4 | 48 | 1 |
C4 | 89 | F | Control | NA | 2/3 | 13 | 2 |
C5 | 91 | F | Control | NA | 3/3 | 19 | 2 |
C6 | 71 | M | Control | NA | NA | 5 | 0 |
C7 | 87 | M | Control | NA | NA | 36 | 1 |
A1 | 85 | F | AD | 4 | 3/4 | 10 | 5 |
A2 | 73 | F | AD | 19 | 3/3 | 14 | 5 |
A3 | 84 | F | AD | 16 | 3/4 | 12 | 5 |
A4 | 92 | M | AD | 22 | 4/4 | 12 | 5 |
A5 | 83 | F | AD | 13 | 3/4 | 12 | 5 |
A6 | 82 | M | AD | 6 | 3/4 | 7 | 6 |
A7 | 91 | F | AD | 14 | 3/4 | 9 | 5 |
A8 | 95 | M | AD | NA | 3/3 | 11 | 6 |